CVS Health Appoints New Board Member
CVS Health has appointed the Chief Data & Analytics Officer of J.P. Morgan to its board of directors, effective November 2026.
Stocks · News reference
AM Best Places Aetna Subsidiaries' Credit Ratings Under Review
AM Best has placed the credit ratings of Aetna Life Insurance Company and other Aetna Health & Life Group members under review with developing implications.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Goldman Sachs Adjusts CVS Health Price Target
Goldman Sachs has revised its price target for CVS Health Corporation, lowering it from $120 to $115.
UBS Maintains Buy on CVS Health, Lowers Price Target to $107
CVS Health Q3 Earnings Call Focuses on Planned Pharmacy Separation
CVS Health announced plans to split into two independent publicly traded companies by the first half of 2028. The continuing CVS Health would retain Aetna, Caremark, and specialty pharmacy operations, while CVS Pharmacy would house retail stores and MinuteClinic. The company raised its 2026 adjusted EPS guidance to at least $8.20 and 2027 EPS to at least $8.65, driven by strong Aetna margin recovery and retail prescription growth, though Caremark faces 340B program headwinds and membership pressures in 2027.
Dow Jumps 1,569 Points, Chipmakers' Growth Beyond Phones, Arm's Server Share Grows
The Dow jumped 1,569 points on Wednesday as the midterm result reset expectations for Washington. Oil fell more than 8%, giving consumer businesses a different backdrop while punishing energy shares. Democrats won
Barclays Adjusts Price Target on CVS Health
Barclays has adjusted its price target for CVS Health Corporation to $107 from $108.